In a filing, Plus Therapeutics Inc revealed its Director Hawkins Richard J acquired Company’s shares for reported $5996.0 on Sep 13 ’24. In the deal valued at $1.50 per share,4,000 shares were bought. As a result of this transaction, Hawkins Richard J now holds 15,188 shares worth roughly $9416.56.
Then, Hawkins Richard J bought 6,285 shares, generating $8,512 in total proceeds. Upon buying the shares at $1.35, the Director now owns 11,188 shares.
Before that, Petersen Greg bought 12,500 shares. Plus Therapeutics Inc shares valued at $16,875 were divested by the Director at a price of $1.35 per share. As a result of the transaction, Petersen Greg now holds 48,921 shares, worth roughly $30331.02.
D. Boral Capital initiated its Plus Therapeutics Inc [PSTV] rating to a Buy in a research note published on March 17, 2025; the price target was $9. A number of analysts have revised their coverage, including Ladenburg Thalmann’s analysts, who began to cover the stock in late January with a ‘”a Buy”‘ rating. Maxim Group began covering PSTV with “Buy” recommendation on October 16, 2020.
Price Performance Review of PSTV
On Monday, Plus Therapeutics Inc [NASDAQ:PSTV] saw its stock fall -4.26% to $0.62. Over the last five days, the stock has lost -26.51%. Plus Therapeutics Inc shares have fallen nearly -46.06% since the year began. Nevertheless, the stocks have fallen -63.94% over the past one year. While a 52-week high of $2.67 was reached on 03/07/25, a 52-week low of $0.24 was recorded on 03/04/25. SMA at 50 days reached $0.8864, while 200 days put it at $1.2416.
Levels Of Support And Resistance For PSTV Stock
The 24-hour chart illustrates a support level at 0.5852, which if violated will result in even more drops to 0.5501. On the upside, there is a resistance level at 0.6502. A further resistance level may holdings at 0.6801. The Relative Strength Index (RSI) on the 14-day chart is 41.61, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0944, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 93.70%. Stochastics %K at 6.36% indicates the stock is a buying.
How much short interest is there in Plus Therapeutics Inc?
A steep rise in short interest was recorded in Plus Therapeutics Inc stocks on 2025-04-15, growing by 0.2 million shares to a total of 1.13 million shares. Yahoo Finance data shows the prior-month short interest on 2025-03-14 was 0.93 million shares. There was a rise of 17.59%, which implies that there is a positive sentiment for the stock.
